Anywhere with a half decent moat and difficulty managing a 'kpi' or outsourcing
Not disregarding your point, but frankly they've shown outperformance in a humanitarian environment that hasn't been solved despite probably billions having been thrown at it.
If she hypothetically gets to run trials for longer stand alone, whatever it takes to see if that outperformance led to a solution or new therapy .. and it did.. she's up for a Nobel, and all this just becomes the slings and arrows
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.001(25.0%) |
Mkt cap ! $3.318M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $500 | 200K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 47 | 36018629 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 15608555 | 20 |
View Market Depth
| Last trade - 15.15pm 31/07/2025 (20 minute delay) ? |
| BIT (ASX) Chart |